INBPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (10 4月 2024 @ 00:42):

Stats
本日の出来高	25.00
平均出来高	3 165.00
時価総額	6.47M
EPS	$0 ( 2024-02-12 )
次の収益日	( $0 ) 2024-05-06
Last Dividend	$0.500 ( 2008-08-19 )
Next Dividend	$0 ( N/A )
P/E	-10.75
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-28	Riva Sheppard	Buy	150 000	Stock Option (right to buy)
2023-11-28	Kay Christina	Buy	150 000	Stock Option (right to buy)
2023-11-28	Masi Dina	Buy	150 000	Stock Option (right to buy)
2023-03-20	Kay E Gerald	Sell	150 000	Stock Option (right to buy)
2023-03-20	Kay E Gerald	Sell	100 000	Stock Option (right to buy)

INSIDER POWER
84.14
Last 98 transactions
Buy: 38 374 999 \| Sell: 953 334

Integrated BioPharma, 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Integrated BioPharma, 財務諸表

Annual	2023
収益:	$50.67M
総利益:	$4.06M (8.01 %)
EPS:	$-0.00110

FY	2023
収益:	$50.67M
総利益:	$4.06M (8.01 %)
EPS:	$-0.00110

FY	2023
収益:	$0
総利益:	$0 (0.00 %)
EPS:	$0

FY	2022
収益:	$56.25M
総利益:	$6.55M (11.65 %)
EPS:	$0.130

Financial Reports:

No articles found.

Integrated BioPharma, Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Integrated BioPharma, Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.86 - low (50.00%) | Divividend Growth Potential Score: 0.991 - No dividend growth expected in the near future

Information

First Dividend	$0.500	2008-08-19
Last Dividend	$0.500	2008-08-19
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.500	--
Avg. Dividend % Per Year	0.00%	--
Score	0.59	--
Div. Sustainability Score	2.86
Div.Growth Potential Score	0.991
Div. Directional Score	1.928	--

Next Divdend (Est)
(2024-04-28)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.59

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for PNK

Symbol	Title	Last dividend	Frequency	Yearly Dividend
BEBE	Ex Dividend Junior	2023-09-18	Quarterly	0.00%
SFDL	Ex Dividend Knight	2023-08-30	Quarterly	0.00%
PPBN	Ex Dividend Knight	2023-08-17	Quarterly	0.00%
ISBA	Ex Dividend Knight	2023-09-26	Quarterly	0.00%
FKYS	Ex Dividend Knight	2023-09-06	Quarterly	0.00%
CNLHN	Ex Dividend Knight	2023-08-09	Quarterly	0.00%
UEPEP	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
RSRV	Ex Dividend Junior	2023-06-06	Annually	0.00%
PFBX	Ex Dividend Knight	2023-05-01	Annually	0.00%
FREVS	Ex Dividend Knight	2023-08-31	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.00615	1.500	-0.123	-0.185	[0 - 0.5]
returnOnAssetsTTM	-0.0150	1.200	-0.499	-0.599	[0 - 0.3]
returnOnEquityTTM	-0.0205	1.500	-1.339	-2.01	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.93	0.800	0.372	0.298	[1 - 3]
quickRatioTTM	0.765	0.800	-0.203	-0.162	[0.8 - 2.5]
cashRatioTTM	0.125	1.500	-0.414	-0.621	[0.2 - 2]
debtRatioTTM	0.0884	-1.500	8.53	-10.00	[0 - 0.6]
interestCoverageTTM	-27.32	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.00942	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00829	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.122	-1.500	9.51	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0535	1.000	-2.44	-2.44	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0109	1.000	-2.22	-2.22	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.125	1.000	-0.419	-0.419	[0.2 - 2]
assetTurnoverTTM	2.43	0.800	10.00	8.00	[0.5 - 2]
Total Score				2.86

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-16.81	1.000	-1.799	0	[1 - 100]
returnOnEquityTTM	-0.0205	2.50	-0.861	-2.01	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00829	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00942	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.125	1.500	-2.50	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.00453	1.000	-2.39	0	[0.1 - 0.5]
Total Score				0.991

Integrated BioPharma,

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.